JPRN-UMIN000015330
Recruiting
Phase 2
A phase II trial of neoadjuvant chemotherapy using the combination of gemcitabine and cisplatin for patients with initially unresectable locally advanced biliary tract cancer. - A phase II trial of neoadjuvant chemotherapy using the combination of gemcitabine and cisplatin for patients with initially unresectable locally advanced biliary tract cancer.
Adjuvant therapy for BTC Research Group0 sites50 target enrollmentOctober 3, 2014
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Biliary tract cancer (Intrahepatic cholangiocarcinoma, Extrahepatic cholangiocarcinoma, Gallbladder carcinoma)
- Sponsor
- Adjuvant therapy for BTC Research Group
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Pulmonary fibrosis or interstitial pneumonia 2\. Severe myelosuppression 3\. Pregnant female, possibly pregnant females, females wishing to become pregnant, and females feeding babies. 4\. Serious renal dysfunction 5\. Serious liver dysfunction 6\. Patients with severe allergy 7\. History of breast or lung radiation 8\. Active infection 9\. Patient with uncontrollable pleural effusion and/or severe edema 10\. Active double cancer 11\. Severe complications including uncontrollable diabetes mellitus. 12\. Severe mental disorder 13\. Inadequate physical condition, as diagnosed by primary physician
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A phase II trial of neoadjuvant chemotherapy with docetaxel,cisplatin and S-1 (DCS) for radically resectable advanced gastric carcinoma (KDOG 1001)radically resectable advanced gastric carcinomaJPRN-UMIN000003642Kitasato University School of Medicine40
Unknown
Phase 2
A Phase II trial of neoadjuvant chemotherapy with S-1 and fractional cisplatin for locally advanced gastric cancerGastric cancerJPRN-UMIN000001777Division of Biological Regulation and Oncology, Department of Surgery, Graduate School of Medicine, Tohoku University25
Completed
Phase 1
Phase I/II trial of neoadjuvant chemotherapy with cisplatin and weekly paclitaxel in patients with stage Ib2- IIb uterine cervical cancerpatients with clinical stage Ib2, IIa(primary tumor diameter4 or more cm),IIb uterine cervical cancerJPRN-UMIN000002636Hyogo Cancer Center40
Recruiting
Phase 1
Phase I/II trial of neoadjuvant chemotherapy with UFT/Leucovorin and Irinotecan plus radiation in patients with locally advanced rectal cancer.ocally advanced rectal cancer with preoperative diagnosis of T3-4 and N0-3.JPRN-UMIN000006208The University of Tokyo Hospital. Department of surgical oncology.39
Completed
Phase 2
A Phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for Stage III gastric cancerStage III gastric cancerJPRN-UMIN000001584Department of Surgery Graduate School of Medicine, Kyoto University49